StockData
Oracle Corp logo

Oracle Corp (ORCL) stock

ORCLNYSEServices-Prepackaged SoftwareFiscal year ends May 31Also trades as ORCL.PD
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Sep 11, 2026Score 19/3035% below fair value
$119.09−6.26 (-4.99%)

Close on Nov 16, 2026Market cap $360.10BP/E 18.7Yield 1.68%

Oracle r&d expenses

Research and development expenses are spending on new products and technology.

Oracle's R&D Expenses for the twelve months ending Aug 31, 2026 was $10.18B, up 1.4% year over year. For fiscal 2026 it was $10.27B, up 4.2% from the year before. Over ten years it grew 5.9% a year on average. The highest annual figure on record is $10.27B in fiscal 2026.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026May 31, 2026$10.27B+4.2%
FY2025May 31, 2025$9.86B+10.6%
FY2024May 31, 2024$8.92B+3.4%
FY2023May 31, 2023$8.62B+19.4%
FY2022May 31, 2022$7.22B+10.6%
FY2021May 31, 2021$6.53B+7.6%
FY2020May 31, 2020$6.07B+0.7%
FY2019May 31, 2019$6.03B-1.0%
FY2018May 31, 2018$6.08B-1.1%
FY2017May 31, 2017$6.15B+6.3%
FY2016May 31, 2016$5.79B+4.8%
FY2015May 31, 2015$5.52B+7.2%
FY2014May 31, 2014$5.15B+6.2%
FY2013May 31, 2013$4.85B+7.2%
FY2012May 31, 2012$4.52B+0.1%
FY2011May 31, 2011$4.52B+38.9%
FY2010May 31, 2010$3.25B+17.6%
FY2009May 31, 2009$2.77B–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$2.40B-3.6%
Q4 FY2026CQ2 2026May 31, 2026$2.61B-1.5%
Q3 FY2026CQ1 2026Feb 28, 2026$2.61B+7.3%
Q2 FY2026CQ4 2025Nov 30, 2025$2.56B+3.6%
Q1 FY2026CQ3 2025Aug 31, 2025$2.49B+8.0%
Q4 FY2025CQ2 2025May 31, 2025$2.65B+19.2%
Q3 FY2025CQ1 2025Feb 28, 2025$2.43B+8.1%
Q2 FY2025CQ4 2024Nov 30, 2024$2.47B+11.0%
Q1 FY2025CQ3 2024Aug 31, 2024$2.31B+4.1%
Q4 FY2024CQ2 2024May 31, 2024$2.23B0.0%
Q3 FY2024CQ1 2024Feb 29, 2024$2.25B+4.8%
Q2 FY2024CQ4 2023Nov 30, 2023$2.23B+3.2%
Q1 FY2024CQ3 2023Aug 31, 2023$2.22B+5.9%
Q4 FY2023CQ2 2023May 31, 2023$2.23B+13.3%
Q3 FY2023CQ1 2023Feb 28, 2023$2.15B+18.2%
Q2 FY2023CQ4 2022Nov 30, 2022$2.16B+23.0%
Q1 FY2023CQ3 2022Aug 31, 2022$2.09B+24.3%
Q4 FY2022CQ2 2022May 31, 2022$1.97B+14.6%
Q3 FY2022CQ1 2022Feb 28, 2022$1.82B+12.0%
Q2 FY2022CQ4 2021Nov 30, 2021$1.75B+9.6%
Q1 FY2022CQ3 2021Aug 31, 2021$1.68B+6.0%
Q4 FY2021CQ2 2021May 31, 2021$1.72B+16.0%
Q3 FY2021CQ1 2021Feb 28, 2021$1.62B+8.1%
Q2 FY2021CQ4 2020Nov 30, 2020$1.60B+4.6%
Q1 FY2021CQ3 2020Aug 31, 2020$1.59B+2.1%
Q4 FY2020CQ2 2020May 31, 2020$1.48B-5.3%
Q3 FY2020CQ1 2020Feb 29, 2020$1.50B+5.2%
Q2 FY2020CQ4 2019Nov 30, 2019$1.53B+3.8%
Q1 FY2020CQ3 2019Aug 31, 2019$1.56B-0.4%
Q4 FY2019CQ2 2019May 31, 2019$1.56B+1.2%
Q3 FY2019CQ1 2019Feb 28, 2019$1.43B-4.7%
Q2 FY2019CQ4 2018Nov 30, 2018$1.48B+0.1%
Q1 FY2019CQ3 2018Aug 31, 2018$1.56B-0.5%
Q4 FY2018CQ2 2018May 31, 2018$1.54B-3.7%
Q3 FY2018CQ1 2018Feb 28, 2018$1.50B-1.6%
Q2 FY2018CQ4 2017Nov 30, 2017$1.47B-2.5%
Q1 FY2018CQ3 2017Aug 31, 2017$1.57B–
Q4 FY2017CQ2 2017May 31, 2017$1.60B–
Q3 FY2017CQ1 2017Feb 28, 2017$1.52B–
Q2 FY2017CQ4 2016Nov 30, 2016$1.51B–

More Oracle figures

See a number that looks wrong?